Spots Global Cancer Trial Database for National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
Official Title: Oligomet-DK. National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
Study ID: NCT04086290
Conditions
Study Description
Brief Summary: A prospective, open label phase 2 clinical trial assessing safety, complications and feasibility of radical prostatectomy (RARP) plus local stereotactic body radiotherapy (SBRT) to bone metastases in combination with short-term medical castration to a select population of prostate cancer patients with oligometastatic disease.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Herlev and Gentofte Hospital, Herlev, , Denmark
Contact Details
Name: Peter B Østergren, MD
Affiliation: Herlev and Gentofte Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
